Cargando…
Early Clinical Response after 2 Weeks of Sorafenib Therapy Predicts Outcomes and Anti-Tumor Response in Patients with Advanced Hepatocellular Carcinoma
BACKGROUND & AIMS: We evaluated the relationship between the early clinical response after 2 weeks of sorafenib therapy and the outcomes and anti-tumor response in patients with advanced hepatocellular carcinoma. METHODS: Fifty-seven patients who had intrahepatic hypervascular hepatocellular car...
Autores principales: | Kuzuya, Teiji, Ishigami, Masatoshi, Ishizu, Yoji, Honda, Takashi, Hayashi, Kazuhiko, Katano, Yoshiaki, Hirooka, Yoshiki, Ishikawa, Tetsuya, Nakano, Isao, Goto, Hidemi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589320/ https://www.ncbi.nlm.nih.gov/pubmed/26421430 http://dx.doi.org/10.1371/journal.pone.0138776 |
Ejemplares similares
-
Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity
por: Yoshioka, Naoki, et al.
Publicado: (2019) -
Liver stiffness measurement predicts hepatocellular carcinoma development in patients treated with direct‐acting antivirals
por: Tachi, Yoshihiko, et al.
Publicado: (2017) -
Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology
por: Ishigami, Masatoshi, et al.
Publicado: (2013) -
Transient deterioration of albumin–bilirubin scores in early post-dose period of molecular targeted therapies in advanced hepatocellular carcinoma with 50% or higher liver occupation: A STROBE-compliant retrospective observational study
por: Muto, Hisanori, et al.
Publicado: (2021) -
Changes in the gut microbiota after hepatitis C virus eradication
por: Honda, Takashi, et al.
Publicado: (2021)